XML 52 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Payment Transactions (Tables)
12 Months Ended
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]  
Schedule of expenses
   Year ended December 31, 
   2021   2020   2019 
   USD 
             
Research and development expenses  $200   $159   $138 
General and administrative expenses   198    158    132 
                
   $398   $317   $270 

 

Schedule of estimated using the binomial option pricing model
Description   2021   2020 
          
Risk-free interest rate    1.22-1.28%   0.93-2.40%
Expected volatility      82.40-82.43%    65.63-78.77 %
Dividend yield    0    0 
Contractual life    10    9.83 - 10 
Early Exercise Multiple (Suboptimal Factor)    3   2.5 - 3 
Exercise price (NIS)    0.25-0.253    0.25 - 2.344 

 

Schedule of weighted average exercise prices and modification in option plans of employees
     
   Shares subject to options
outstanding
 
   2021 
   Number   Weighted
average
exercise
price
 
       USD 
Outstanding at beginning of year   11,923,400    0.28 
Grants   7,100,000    0.08 
Forfeited/expired   (600,700)   1.00 
           
Outstanding at end of year   18,422,700    0.18 
           
Exercisable at end of year   6,322,700    0.35 

 

Schedule of options outstanding classified by exercise price
Outstanding   Exercisable 
Exercise price per share   Options
outstanding
   Weighted
average
remaining
contractual
life in
years
   Weighted
average
exercise
price per
share
   Options
exercisable
   Weighted
average
exercise
price per
share
 
$0.08 - $0.94    17,796,500                8.32   $                  0.13                5,696,500   $             0.21 
$1.09 - $1.73    555,000    0.14   $0.04    555,000   $0.11 
$2.61 - $5.18    71,200    0.01   $0.01    71,200   $0.04 
      18,422,700              6,322,700